IVF
Price
$1.24
Change
-$0.08 (-6.06%)
Updated
Jun 25 closing price
Capitalization
2.22M
48 days until earnings call
Intraday BUY SELL Signals
RANI
Price
$0.74
Change
-$0.03 (-3.90%)
Updated
Jun 25 closing price
Capitalization
83.19M
41 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IVF vs RANI

IVF vs RANI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IVF vs. RANI commentary
Jun 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVF is a StrongBuy and RANI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2026
Stock price -- (IVF: $1.25 vs. RANI: $0.74)
Brand notoriety: IVF and RANI are both not notable
IVF represents the Medical/Nursing Services, while RANI is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVF: 22% vs. RANI: 51%
Market capitalization -- IVF: $2.22M vs. RANI: $83.19M
IVF [@Medical/Nursing Services] is valued at $2.22M. RANI’s [@Biotechnology] market capitalization is $83.19M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $162.41B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $121.87B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.53B. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVF’s FA Score shows that 1 FA rating(s) are green whileRANI’s FA Score has 1 green FA rating(s).

  • IVF’s FA Score: 1 green, 4 red.
  • RANI’s FA Score: 1 green, 4 red.
According to our system of comparison, RANI is a better buy in the long-term than IVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IVF’s TA Score shows that 4 TA indicator(s) are bullish while RANI’s TA Score has 2 bullish TA indicator(s).

  • IVF’s TA Score: 4 bullish, 4 bearish.
  • RANI’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, IVF is a better buy in the short-term than RANI.

Price Growth

IVF (@Medical/Nursing Services) experienced а -17.00% price change this week, while RANI (@Biotechnology) price change was -5.39% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +18.91%. For the same industry, the average monthly price growth was +2.88%, and the average quarterly price growth was -12.05%.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.11%. For the same industry, the average monthly price growth was +3.10%, and the average quarterly price growth was +1836.60%.

Reported Earning Dates

IVF is expected to report earnings on Aug 13, 2026.

RANI is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Medical/Nursing Services (+18.91% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Biotechnology (+6.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RANI($83.2M) has a higher market cap than IVF($2.22M). RANI YTD gains are higher at: -45.170 vs. IVF (-66.915). IVF has higher annual earnings (EBITDA): -9.34M vs. RANI (-33.38M). RANI has more cash in the bank: 43.4M vs. IVF (356K). RANI has less debt than IVF: RANI (3.94M) vs IVF (4.23M). IVF has higher revenues than RANI: IVF (6.94M) vs RANI (3.17M).
IVFRANIIVF / RANI
Capitalization2.22M83.2M3%
EBITDA-9.34M-33.38M28%
Gain YTD-66.915-45.170148%
P/E Ratio0.01N/A-
Revenue6.94M3.17M219%
Total Cash356K43.4M1%
Total Debt4.23M3.94M107%
FUNDAMENTALS RATINGS
IVF: Fundamental Ratings
IVF
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IVFRANI
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
79%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IVF
Daily Signal:
Gain/Loss:
RANI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBIO69.690.33
+0.48%
BridgeBio Pharma
KLC4.190.01
+0.24%
KinderCare Learning Companies Inc
EEFT67.06-0.44
-0.65%
Euronet Worldwide
ASPS7.03-0.17
-2.29%
Altisource Portfolio Solutions S.A.
AIXI2.12-0.26
-11.10%
XIAO-I Corporation

IVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVF has been closely correlated with INBS. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if IVF jumps, then INBS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVF
1D Price
Change %
IVF100%
-5.68%
INBS - IVF
78%
Closely correlated
-1.82%
VNDA - IVF
40%
Loosely correlated
-0.85%
IVA - IVF
30%
Poorly correlated
+1.16%
RANI - IVF
30%
Poorly correlated
-3.49%
IRD - IVF
27%
Poorly correlated
+0.40%
More

RANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with ARTV. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
-3.49%
ARTV - RANI
45%
Loosely correlated
-5.26%
IRON - RANI
37%
Loosely correlated
-0.42%
ACHV - RANI
35%
Loosely correlated
+7.45%
VYGR - RANI
32%
Poorly correlated
-3.53%
DRUG - RANI
31%
Poorly correlated
-3.87%
More